The CA1 region of 6‐OHDA‐injected rats showed increased levels of pS404 tau immunoreactivity, predominantly in the somatodendritic region, which is reminiscent of tau changes during early tauopathy development [78]. The gene discussed is MAPT; the disease is tauopathy.